ArticleBreast cancer (Tokyo, Japan)2024

Overall survival in Japanese patients with ER+/HER2- advanced breast cancer treated with first-line palbociclib plus letrozole.

Masato Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.